Company intelligence / Profile preview

Fusion Bioscience

Shanghai, Shanghai Municipality, Chinaprnewswire.com ↗

Ownership: Private
Development stage: Other

Overview

Fusion Bioscience (Shanghai) Co. Ltd. is a privately held contract research organization founded in 2021 and based in Shanghai, China. It offers specialized R&D services to life science and pharmaceutical companies, focusing on antibody engineering, aptamer development, chimeric antigen receptor engineering, and CRISPR/Cas9 genome editing support. The team comprises experienced biotech professionals with expertise in antibody sequencing/engineering, phage display library panning, recombinant protein production, CAR-T cell functional testing support, and nucleic acid aptamer development.

Modalities: AntibodyAptamerChimeric antigen receptor therapy (for research)CRISPR-based therapy (for research)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Fusion Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fusion Bioscience.

Explore the full profile